Breakpoints for Predicting Pseudomonas Aeruginosa Susceptibility to Inhaled Tobramycin in Cystic Fibrosis Patients: Use of High-Range Etest Strips

Journal of Clinical Microbiology - United States
doi 10.1128/jcm.43.9.4480-4485.2005
Full Text
Abstract

Available in full text

Categories
Microbiology
Date
Authors
Publisher

American Society for Microbiology

Related search

The Susceptibility of Pseudomonas Aeruginosa Strains From Cystic Fibrosis Patients to Bacteriophages

PLoS ONE
Multidisciplinary
2013English

The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas Aeruginosa Infection in Non-Cystic Fibrosis Bronchiectasis

Journal of Aerosol Medicine and Pulmonary Drug Delivery
PulmonaryRespiratory MedicinePharmacologyPharmaceutical Science
2018English

Immunization of Noncolonized Cystic Fibrosis Patients Against Pseudomonas Aeruginosa

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
1994English

Eradication of Pseudomonas Aeruginosa in Cystic Fibrosis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2006English

Treatment of Pseudomonas Aeruginosa Colonisation in Cystic Fibrosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

In Vitro Activity of Aztreonam Combined With Tobramycin and Gentamicin Against Clinical Isolates of Pseudomonas Aeruginosa and Pseudomonas Cepacia From Patients With Cystic Fibrosis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Pseudomonas Aeruginosa in Cystic Fibrosis: A Chronic Cheater

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Synergistic Activity of a Short Lipidated Antimicrobial Peptide (lipoAMP) and Colistin or Tobramycin Against Pseudomonas Aeruginosa From Cystic Fibrosis Patients

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2016English

Development of Levofloxacin Inhalation Solution to Treat Pseudomonas Aeruginosa in Patients With Cystic Fibrosis

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy